The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
Marilyn T. Wan, Daniel B. Shin, Kevin Winthrop, Joel M. Gelfand
Topics & Concepts
MedicineImmunologyPsoriasisImmunosuppressionDiseaseProinflammatory cytokineScopusMEDLINEInternal medicineInflammationPolitical scienceLawPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAutoimmune and Inflammatory Disorders Research